Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future NYT > Top Stories By: Eshe Nelson 1 September 2026 at 17:06 Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs. © Juan Diego Reyes for The New York TimesNovo’s share price is languishing about 70 percent below its peak from mid-2024, when it was Europe’s most valuable public company.
The Ritual of Coffin Making in a City Hit by Ebola NYT > Top Stories By: Matthew Mpoke Bigg and Arlette Bashizi 1 September 2026 at 07:01 While several coffin makers in Bunia said they were providing a public service, the virus has put them at the center of a debate around safe burials. © Arlette Bashizi for The New York Times
Login
